Singapore Exchange · Healthcare
Invest in Tianjin Pharmaceutical Da Ren Tang Group stock from India
Indian and foreign residents can buy Tianjin Pharmaceutical Da Ren Tang Group (T14) shares directly through Paasa.
By Paasa · Updated
Tianjin Pharmaceutical Da Ren Tang Group at a glance
- Price
- $2.52-$0.02 (0.79%)
- Market cap
- $3.25B
- Day range
- $2.52 – $2.54
- P/E
- 32.04
- Dividend yield
- 13.56%
- Volume
- 7.30K
- 1 month
- -1.18%
- 6 months
- -21.98%
- YTD
- -26.10%
- 1 year
- -13.70%
- 5 years
- +142.31%
Tianjin Pharmaceutical Da Ren Tang Group statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CN¥4.9B | CN¥7.3B | CN¥8.2B | CN¥8.2B | CN¥6.9B |
| Gross profit | CN¥3.6B | CN¥3.5B | CN¥3.6B | CN¥3.3B | CN¥2.8B |
| Operating income | CN¥2.5B | CN¥2.6B | CN¥1.1B | CN¥980.0M | CN¥866.7M |
| Net income | CN¥2.1B | CN¥2.2B | CN¥986.7M | CN¥861.8M | CN¥769.1M |
| Earnings per share | CN¥2.77 | CN¥2.90 | CN¥1.28 | CN¥1.12 | CN¥1.00 |
| EBITDA | CN¥2.6B | CN¥2.7B | CN¥1.3B | CN¥1.1B | CN¥991.3M |
| Total assets | CN¥11.7B | CN¥10.8B | CN¥10.2B | CN¥10.2B | CN¥9.1B |
| Total debt | CN¥62.6M | CN¥27.3M | CN¥325.6M | CN¥257.9M | CN¥33.2M |
| Cash and short-term investments | CN¥1.0B | CN¥3.9B | CN¥2.1B | CN¥2.9B | CN¥2.3B |
| Shareholders' equity | CN¥7.1B | CN¥7.8B | CN¥6.6B | CN¥6.5B | CN¥6.4B |
| Operating cash flow | CN¥461.1M | CN¥924.7M | CN¥688.5M | CN¥677.2M | CN¥852.4M |
| Free cash flow | CN¥342.5M | CN¥806.9M | CN¥547.6M | CN¥569.3M | CN¥695.5M |
| Capital expenditure | −CN¥118.6M | −CN¥117.8M | −CN¥140.9M | −CN¥107.9M | −CN¥156.9M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CNY; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Haw Par | H02.SI | S$13.07 | S$2.89B |
| China Aviation Oil (Singapore) | G92.SI | S$1.35 | S$1.16B |
| Yanlord Land | Z25.SI | S$0.54 | S$1.03B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Tianjin Pharmaceutical Da Ren Tang Group from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.
Step 3
Search T14 and buy
Find Tianjin Pharmaceutical Da Ren Tang Group by name or by its ticker, T14, and place your order.
Why invest in Tianjin Pharmaceutical Da Ren Tang Group from India
What Tianjin Pharmaceutical Da Ren Tang Group does
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (TPDRTG), a prominent pharmaceutical group operating with its various subsidiaries, primarily serves the People's Republic of China. Its core focus lies in the production and sale of traditional Chinese medicines, Western pharmaceuticals, and health-related products. Tianjin Pharmaceutical Da Ren Tang Group operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Hold a dollar asset
Tianjin Pharmaceutical Da Ren Tang Group shares are priced in US dollars, so a weaker rupee adds to what they're worth in rupees. The rupee depreciated over 85% against the dollar between 2010 and 2025.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Tianjin Pharmaceutical Da Ren Tang Group stock from India?
Yes. Indian residents and NRIs can buy Tianjin Pharmaceutical Da Ren Tang Group (T14) shares directly through Paasa. Tianjin Pharmaceutical Da Ren Tang Group is listed on the Singapore Exchange, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Tianjin Pharmaceutical Da Ren Tang Group dividends taxed for Indian investors?
Tianjin Pharmaceutical Da Ren Tang Group trades on the Singapore Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Singapore. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Tianjin Pharmaceutical Da Ren Tang Group shares?
Singapore does not levy capital gains tax on the sale of shares, ETFs or REITs. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the USD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.